跳至主要内容
临床试验/NCT00496041
NCT00496041已完成不适用

Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-classification

University Hospital, Ghent2 个研究点 分布在 1 个国家目标入组 205 人开始时间: 2007年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
205
试验地点
2
主要终点
Patency as defined by absence of occlusion or >50% restenosis rate at the level the treated lesion as determined by duplex control.

研究概览

简要总结

This is a Belgian prospective multicentre registry on the performance of the Smart stent in the superficial femoral artery according to the new tasc II-classification.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stenosis (> 75%) or occlusion of the superficial femoral artery (lesion up to 3 cm distal to Hunter's canal)
  • New TASC (2007) A, B, or C lesions
  • Vessel diameter between 4.5 and 6.5 cm
  • Debilitating claudication or critical limb ischemia (Rutherford 2 to 5)
  • At least 1 outflow vessel down to the ankle
  • Signed informed consent
  • > Age 50, life expectancy > 1 year
  • Capable of concluding the necessary follow-up visits

排除标准

  • Refusal to participate in the study
  • Acute ischemia
  • Inflow lesions > 50%, not successfully corrected before the procedure
  • Combination with other treatment with the exception of treatment to improve the inflow

结局指标

主要结局

Patency as defined by absence of occlusion or >50% restenosis rate at the level the treated lesion as determined by duplex control.

时间窗: 1 year

次要结局

  • Clinical success rate defined on improvement in symptoms according to the Rutherford classification by a minimum of 1 class.(1 year)
  • Patency as defined by absence of occlusion, whether or not after additional intervention to maintain this patency (primary and secondary patency rate)(1 year)
  • Target lesion revascularisation rate as defined by the number of new revascularisations (endovascular or open) carried out due to restenosis at the level of the stented lesion(1 year)
  • Target vessel revascularisation rate as defined by the number of new revascularisations (endovascular or open) carried out due to restenosis or a new stenosis in the SFA.(1 year)
  • Limbs-salvage rate(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验